TM
ENZY

Tiger Management’s Enzymotec Ltd ENZY Stock Holding History

Tiger Management’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-677,548
Closed -$7.76M – 88
2017
Q3 		$7.76M Hold
677,548
– – 1.4% 22
2017
Q2 		$5.49M Hold
677,548
– – 1.08% 24
2017
Q1 		$5.96M Hold
677,548
– – 1.12% 25
2016
Q4 		$4.44M Hold
677,548
– – 0.8% 24
2016
Q3 		$4.74M Buy
677,548
+100,141
+17% +$803K 1.12% 19
2016
Q2 		$4.83M Sell
577,407
-565,738
-49% -$4.69M 1.56% 16
2016
Q1 		$10.3M Sell
1,143,145
-19,700
-2% -$172K 2.59% 18
2015
Q4 		$11.4M Buy
1,162,845
+357,991
+44% +$3.39M 1.47% 22
2015
Q3 		$7.28M Buy
+804,854
New +$7.18M 0.97% 27

Other funds holding ENZY

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
DG
Delek Group Herzliya, Israel $2.59B AUM 1.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
GH
GAM Holding Zurich, Switzerland $1.31B AUM 35.17% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
CRA
Circle Road Advisors New York $27.7M AUM 35.85% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tiger Management's ENZY Position: Q4 2017 in Review

Tiger Management sold out of Enzymotec Ltd (ENZY) in Q4 2017, closing a stake of 677,548 shares — an estimated $7.76M sold.

Tiger Management first reported a position in ENZY in Q3 2015 and held it in 9 quarters. The position peaked at $11.4M in Q4 2015. 37 funds tracked by Wall St. Rank hold ENZY as of Q4 2017.

  • Tiger Management reported no remaining Enzymotec Ltd position as of Q4 2017 after selling out during the quarter.
  • Tiger Management sold 677,548 Enzymotec Ltd shares in Q4 2017, an estimated $7.76M.
  • Tiger Management first reported a position in Enzymotec Ltd in Q3 2015 and held it in 9 quarters.
  • Tiger Management's Enzymotec Ltd position peaked at $11.4M in Q4 2015.
  • 37 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q4 2017.

Based on Tiger Management's 13F filing for Q4 2017, filed 14 Feb 2018.